Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

NCT01393743 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT01393743
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01393743 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures
Lead sponsor
Eisai Inc.
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2011
Completion date
November 30, 2015
Enrollment
163 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

seizure disorder generalized tonic clonic